# Cadonilimab Combined With S-1 or Capecitabine as Second-line Treatment for Advanced Pancreatic Cancer

Source: https://onco.cc/trials/nct06532617/  
OnCo record `nct06532617` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of cadonilimab in pancreatic cancer, run by Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, now recruiting.

## Summary

Cadonilimab Combined With S-1 or Capecitabine as Second-line Treatment for Advanced Pancreatic Cancer is a phase 2, interventional study registered as NCT06532617 by Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, with a registry enrolment figure of 30 participants, started 2024-09-19 and due to reach its primary completion in 2026-08-01. Interventions recorded: Cadonilimab+S-1or Capecitabine. Conditions listed: Pancreatic Neoplasms. Primary outcome: Objective response rate (ORR). Pancreatic eligibility wording from the registry: "* Histopathologically confirmed pancreatic ductal adenocarcinoma". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT06532617
- Phase: 2
- Setting: A Single-arm Phase II Clinical Study of Cadonilimab Combined With S-1 or Capecitabine as Second-line Treatment for Patients With Advanced Pancreatic Cancer
- Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Enrolled: 30

## Sources

- ClinicalTrials.gov NCT06532617: https://clinicaltrials.gov/study/NCT06532617

## Connected records

- cancers: [Metastatic pancreatic ductal adenocarcinoma](https://onco.cc/cancers/metastatic-pdac/)
- technologies: [Immune checkpoint inhibitors](https://onco.cc/technologies/checkpoint-inhibitor/)
- drugs: [Cadonilimab](https://onco.cc/drugs/cadonilimab/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06532617.json